OVERVIEW
The Prosthetic Heart Valve / Artificial Heart Valve market is projected to reach USD 12.6 billion by 2025, rising over the forecast period at a CAGR of 11.7%. Market growth can be attributed to the rising geriatric population and the subsequent increase in HVD prevalence, regulatory approvals for new and advanced heart valves, increased awareness of HVD, and favorable heart valve reimbursement scenario.
TABLE OF CONTENT
1 Global Prosthetic Heart Valve / Artificial Heart Valve Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Prosthetic Heart Valve / Artificial Heart Valve Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Prosthetic Heart Valve / Artificial Heart Valve Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Prosthetic Heart Valve / Artificial Heart Valve Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Prosthetic Heart Valve / Artificial Heart Valve Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Prosthetic Heart Valve / Artificial Heart Valve Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Prosthetic Heart Valve / Artificial Heart Valve Market – By Type of Valve (Market Size –
& million/billion)
8.1 Transcatheter Heart Valve
8.2 Tissue Heart Valve
8.3 Mechanical Heart Valve
9 Global Prosthetic Heart Valve / Artificial Heart Valve Market – By Geography (Market Size –
& million/billion)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 U.K
9.3.2 Germany
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Rest of APAC
9.5 Rest of the World
9.5.1 South America
9.5.2 Middle East
9.5.3 Africa
10 Global Prosthetic Heart Valve / Artificial Heart Valve Market – Entropy
10.1 New product launches
10.2 M&A’s, collaborations, JVs and partnerships
11 Global Prosthetic Heart Valve / Artificial Heart Valve Market Company Profile (Key Players)
11.1 Market Share, Company Revenue, Products, M&A, Developments
11.2 Medtronic PLC
11.3 Edwards Lifesciences Corporation
11.4 Boston Scientific Corporation
11.5 Livanova PLC
11.6 St. Jude Medical, Inc. (An Abbott Laboratories Company)
11.7 Jenavalve Technology, Inc.
11.8 TTK Healthcare Limited (A TTK Group Company)
11.9 Colibri Heart Valve, LLC
11.10 Symetis SA
11.11 Cryolife, Inc.
11.12 Company 11 & more
12 Global Prosthetic Heart Valve / Artificial Heart Valve Market – Appendix
12.1 Sources
12.2 Abbreviations